Skip to main content
Funded Studies

Sam Jackson, MD, MBA

Chief Medical Officer at Alkahest, Inc.

Location: San Carlos, CA United States

Dr. Sam Jackson leads clinical drug development efforts at Alkahest, a biotechnology company whose mission is to enrich the health and vitality of humankind through transformative therapies that counterbalance the aging process. Dr. Jackson has extensive experience in drug development, most recently at Dynavax, where he led the Drug Safety Group and designed and conducted vaccine and asthma clinical trials. Dr. Jackson also led drug development teams at Genentech in diverse therapeutic areas including immunology, hepatology and ophthalmology. He started his career in industry at Amgen, where he was responsible for the safety for a broad array of molecules in various stages of development.

Dr. Jackson has an undergraduate degree from Stanford and is a graduate of the MD/MBA program at the University of Pennsylvania/Wharton. He completed his residency in emergency medicine at UC Davis in Sacramento, California, and his fellowship in medical toxicology at Banner Good Samaritan Hospital in Phoenix, Arizona.

Associated Grants

  • Blood Proteins for the Treatment of Parkinson’s Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.